uth Due to reports of interferon alpha exacerbating pre-existing psoriatic disease and sarcoidosis, use of Viraferon in patients with psoriasis or sarcoidosis is recommended only if the potential benefit justifies the ###>En raison de la survenue de cas de réactivation de psoriasis et de sarcoïdose sous interféron alpha,